DXS INTERNATIONAL PLC
Issue of Ordinary Shares
The Board of DXS International plc (the “Company”), the NEX quoted clinical decision support developer and supplier of clinical decision support systems is pleased to announce that on it has received and accepted an application from a new investor for the issue of 1,785,000 Ordinary shares at a subscription price of 7p per share.
Following this issue, completed on 28th September 2018, the issued share capital of the Company is now 35,181,416 ordinary shares. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.
The new shareholder, Mr Anthony Carr, holds 1,785,000 Ordinary Shares constituting 5.07 per cent of the total ordinary shares in issue
The Directors of DXS International plc accept responsibility for this announcement
Enquiries:
| David Immelman (Chief Executive) DXS International plc | 01252 719800 david@dxs-systems.com |
| Wrecclesham House Wrecclesham Road Farnham Surrey GU10 4PS | |
| www.dxs-systems.co.uk |
| David Papworth City & Merchant | 0207 101 7676 info@cityandmerchant.com |
| Level 17, Dashwood House 69 Old Broad Street, London EC2M 1QS |
Note to Editors:
DXS International presents up to date treatment guidelines and recommendations, from Clinical Commissioning Groups and other trusted NHS sources, to doctors, nurses and pharmacists in their workflow and during the patient consultation. This effective clinical decision support ultimately translates to improved healthcare outcomes delivered more cost effectively which should significantly contribute towards the NHS achieving its projected efficiency savings.